Shimon Sakaguchi

Dr. Sakaguchi, M.D., Ph.D. Professor, Osaka University, discovered regulatory T (Treg) cells, which compose of five percent of T cells and are specialized for immuno-supression. He has being studying the molecular basis of the development of naturally occurring Treg cells, and also human Treg cells, in particular, analyzing anti-tumor immune responses against adult T-cell leukemia, shedding new light on cancer immunotherapy. He was elected as a member of National Academy of Sciences in 2012 and was also selected as one of the “Highly Cited Researchers” by Thomson Reuters CO, USA.

Sort options

The Immune System: New Developments in Research - Part 1 (edX)

Basic principles of immunology including the latest topics leading to novel therapeutic approaches. This course will provide fundamental knowledge in immunology as well as some advanced topics from cutting-edge research results, such as cancer immunotherapy and novel vaccine development. Immunity is the body’s system of protection from attack by pathogens [...]
Average: 9 ( 2 votes )